Jurcau 2016.

Methods	Study type: interventional (clinical trial) Actual enrolment: 89 Allocation: randomised Intervention model: parallel assignment Masking: unclear Primary purpose: treatment
Participants	Country: Romania Setting: inpatient At randomisation numbers allocated: N = 89 Experimental group: escitalopram = 43 Comparator group: ?secondary preventive treatment = 46 % male: unclear Age: unclear Subtype of stroke: unclear Severity of stroke: unclear Time since stroke onset: unclear Inclusion criteria: unclear Exclusion criteria: unclear withdrawal criteria: unclear
Interventions	Experimental: escitalopram 10 mg/day for 12 weeks Comparator: ?secondary preventive treatment = 46
Outcomes	Outcomes collected at 3, 6 and 12 months post‐stroke NIHSS BI MMSE BDI HAM‐D17
Notes	Does not appear to be a clinical trial register number

BDI: Beck Depression Inventory
 BI: Bathel Index
 FIM: Functional Independence Measure
 HAM‐D17: Hamilton Depression Scale
 MMSE: Mini‐Mental State Examination
 NIHSS: National Institutes of Health Stroke Scale
 od: once daily